Table 1.
Demographic characteristics of study cohorts.
Figure 1.
Gel electrophoresis profile of the PWG gliadin preparation used for the anti-gliadin antibody assays.
A) 5 µg of protein loaded; B) 10 µg of protein loaded.
Figure 2.
Comparison of levels of IgG and IgA antibody to gliadin in children with autism, their unaffected siblings, and unrelated healthy controls.
Boxed segments represent the middle 50% of the data. Whiskers indicate the range of data. Large horizontal bars indicate mean value of the data. ** = p<0.01.
Figure 3.
Comparison of levels of antibody to A) gliadin, B) deamidated gliadin fusion peptide, and C) human TG2 in autistic children, with and without GI symptoms.
Boxed segments represent the middle 50% of the data. Whiskers indicate the range of data. Large horizontal bars indicate mean value of the data. ** = p<0.01.